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ABSTRACT  
The present research work aims to develop a novel ultraviolet UV spectrophotometric method for the determination of Amlodipine Besylate 
using Benzoyl Chloride as a derivatizing agent, which is simple, rapid, sensitive, selective, and accurate method for the spectrophotometric 
determination of Amlodipine Besylate in powder form.  Synthesis is based upon the Schotten Baumann Reaction. In this method, derivatization 
of aliphatic amine group of Amlodipine Besylate carried out with benzoyl chloride and aqueous sodium hydroxide (NaOH).The λmax was found 
to be 237 and 226nm for assay of Amlodipine Besylate and synthesised product respectively. The linearity was found in concentration range of 
1-10 μg/ml. The correlation coefficient (r2)was found 0.9985. The regression equation, intercept (a) and slope (b) was found as Y=0.0762x - 
0.0077, 0.0077 and 0.0762 respectively. Method was developed and validated as per ICH guidelines for linearity, accuracy, precision, LOD, LOQ, 
interday and intraday. The LOD and LOQ for estimation of Amlodipine besylate were found as 0.2367, 0.7178 respectively. Recovery of 
Amlodipine besylate was found to be 93.30%.The proposed method is found to be simple, rapid, selective and highly sensitive than most of the 
Spectrophotometric methods available in literature. 
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Amlodipine Besylate is 3-ethyl 5 methyl(4RS)-2-
[(2aminoethoxy) methyl]-4-(2-chlorophenyl)-6-methyl-1,4-
dihydropyridine-3,5-dicarboxylate benzene sulphonate.1 
Amlodipine Besylateis a dihydropyridine calcium-channel 
blocker that inhibits the transmembrane influx of calcium 
ions into vascular smooth muscles and cardiac muscles, 
which in turn affects their contractile process and results in 
reduced blood pressure. It is used in the treatment of 
hypertension and angina.2 
However, latest findings have revealed that its efficacy is not 
only limited to the treatment of cardiovascular diseases as it 
has shown to possess antioxidant activity and plays an 
important role in apoptosis. Therefore, it is also employed in 
the treatment of cerebrovascular stroke, neurodegenerative 
diseases, leukemia, breast cancer, and so forth either alone 
or in combination with other drugs.3Amlodipine is used in 
the management of hypertension1 and coronary artery 
disease. Itis available in several officials in Pharmacopoeia. 
Literature survey reveals that, Spectrophotometric methods, 
HPLC, HPTLC, UPLC.4Amlodipine Besylate is freely soluble in 
methanol, slightly soluble in 2-propanol and water and 
sparingly soluble in ethanol 95%.5 Amlodipine Besylate 
contains not less than 97.0 per cent and not more than 102.0 
per cent of C26H31ClN208S, calculated on the anhydrous basis. 
Category. Antihypertensive; antianginal.6 
It is marketed as the benzene sulfonic acid salt (besylate). 
Amlodipine was approved in September 2007 as a 
combination product with olmesartan (Azor), an angiotensin 
II receptor antagonist, for the treatment of hypertension. 
Amlodipine is also marketed as a combination therapy with 
atorvastatin under the tradename Norvasc for the 
management of high cholesterol and high blood pressure.7 
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Molecular structure: 
 
Molecular weight: 567.1 gm/mol 
Molecular formula: C26H31ClN2O8S 
Melting point: 199-201 0C 
 
MATERIALS AND METHODS 
Instruments 
A double beam Shimadzu UV-1800 series spectrophotometer 
was used. Absorption and overlain spectra of both test and 
standard solutions were recorded over the wavelength range 
of 200-400nm using 1cm quartz cell at fast scanned speed 
and fixed slit width of 1.0 nm. All weighing of ingredients 
were done on ohaus digital weighing balance.8 
Reagents and standards 
All the ingredients are taken from Ali – Allana College of 
Pharmacy Akkalkuwa (Pharmaceutical Chemistry 
laboratory) like Amlodipine Besylate, Methanol, NaOH, etc. 
Preparation of Standard Stock Solution 
About 100 mg of Amlodipine Besylate and Synthesised 
Product was weighed accurately and transferred in to 100 ml 
of volumetric flask respectively. The volume was made up to 
100 ml using distilled water to obtain a solution that has a 
concentration 1000 μg/ml. 1 ml of above  solution was taken 
and diluted up to 10 ml using distilled water to obtain  a 
solution that has a concentration 100 μg/ml. The above 10 
ml solution was taken and diluted up to 100 ml using 
distilled water to obtain a solution that has a concentration 
10 μg/ml. From above stock solution 1ml, 2 ml, 3ml, 4ml, 
5ml, 6ml, 7ml, 8ml, 9ml and 10ml solution were taken in 
separate volumetric flask and diluted using distilled water up 
to 10 ml to each to obtain solution that has concentration 
1μg/ml, 2μg/ml, 3μg/ml, 4μg/ml, 5μg/ml, 6μg/ml, 7μg/ml, 
8μg/ml, 9μg/ml and 10μg/ml respectively.   
Calibration Curve  
The standard solutions of Amlodipine Besylate and 
Synthesised Product were diluted with methanol individually 
to get the concentration of 10µg/ml and 10µg/ml 
respectively and were scanned in the UV range 400-200nm. 
The λmax of both the drugs were found to be 237nm and 226 
nm respectively. The spectral data was processed to obtain 
first order derivative spectrum at wavelength interval of 2 
nm and scaling factor 10 for the range of 400-200nm with 
scanning speed of 400nm/min. It was observed that 
Amlodipine Besylate shows zero crossing at 237nm while 
Synthesised Product shows zero crossing at 226nm. At zero 
crossing point of Amlodipine Besylate (237nm), Synthesised 
Product showed a measurable dA/dλ whereas at zero 
crossing point of Synthesised Product(226nm), Amlodipine 
Besylate showed a measurable dA/dλ. Hence the 
wavelengths 237nm and 226nm were selected as analytical 
wavelengths for determination of Amlodipine Besylate and 
Synthesised Product first order derivative method 
respectively.9 
Preparation of Sample Solution 
About 50 mg of Amlodipine Besylate and Synthesised 
Product pure drug was weighed accurately and transferred 
in to 50 ml of volumetric flask respectively. The volume was 
made up to 50 ml using distilled water to obtain a solution 
that has a concentration 1000 μg/ml. 1 ml of above  solution 
was taken and diluted up to 10 ml using distilled water to 
obtain  a solution that has a concentration 100 μg/ml. The 
above 10 ml solution was taken and diluted up to 100 ml 
using distilled water to obtain a solution that has a 
concentration 10 μg/ml. From above stock solution 1ml, 2ml, 
3ml, 4ml, 5ml, 6ml, 7ml, 8ml, 9ml and 10ml of Amlodipine 
Besylate and Synthesised Product were taken and diluted up 
to 10ml to obtain 1μg/ml, 2μg/ml, 3μg/ml, 4μg/ml, 5μg/ml, 
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1. Place 1.0gm (0.99 ml) of amlodipine besylate and 9.61 
ml of 10% aqueous sodium hydroxide solution in an 
iodine flask and then add 1.35 ml (1.65) of benzoyl 
chloride, stopper the flask and shake vigorously for 10 
min. heat is evolved in the reaction. The crude benzoyl 
derivative separates as white powder. 
2. When the reaction is complete i.e. when the odour of 
benzoyl chloride can no longer be detected (smell 
cautiously) make sure that reaction mixture is alkaline 
and dilute it with 4.42 ml of water. 
3. Filter off the product with suction on a small Buchner 
fullel, break up the mass (if necessary) wash well with 
water, and drain  
4. Recrystallise from hot alcohol (methylated spirit) filter 
the hot solution through a hot water funnel or through 
a warm Buchner funnel. Collect the crystals which are 
separated and dry in the air or in the steam oven. 
5. Report the yield and melting point  
6. The yield of benzanilide is 0.59 gm. 




Molecular formula: C33H35ClN2O9S 
Molecular weight: 671.1 
Solubility: Methanol 
Melting point: 108-110 0 C 
Amides 
In recent year with the introduction of new peptides 
coupling reagent in organic synthesis, the method of amide 
synthesis have been significantly advanced. But the two step 
acylation, activation of carboxylic acid a reaction with amines 
have been often used in nonpeptide chemistry. Acid chloride 
are generally recognised as key intermediate for acylation, 
for conversion into many other function groups along with 
amides such as anhydride, ester and ketones. An acylation 
with technique of protecting group in multistep synthetic 
processes, important synthetic routes for many bio active 
compounds such as vitamins, agrochemicals, xanthine’s and 
in combinational peptides synthesis.11 
Validation 
The UV Spectrophotometric methods were validated as per 
ICH Q2A guidelines. Parameters like Sensitivity, Linearity, 
Range, Accuracy, Precision, Limit of detection (LOD), Limit of 
quantification (LOQ) and Robustness were evaluated.12 
Linearity: 
For each drug, appropriate dilutions of standard stock 
solutions were assayed as per the developed methods. The 
Beer-Lambert’s concentration range was found to be 1-10 
μg/ml for Paracetamol and 1-10 μg/ml for Phenylephrine 
HCl. The linearity data for method is presented in Table1.13 
Accuracy: 
To check the accuracy of the proposed method recovery 
studies were carried out at 80, 100, 120 % of the test 
concentration as per ICH guidelines. The recovery study was 
performed three times at each level. The results of the 
recovery studies are reported in Table1.14 
Precision: 
Precision was determined by studying the repeatability and 
intermediate precision. 
Interday and Intraday precision: 
The interday and intraday precision was determined by 
assay of the sample solution on the interday precision was 
determined by assay of the sample solution on the same day 
and on  different days at different time interval 
respectively.15 
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Limit of detection (LOD) and Limit of Quantification 
(LOQ): 
The Limit of Detection (LOD) is the smallest concentration of 
analyte that give the measurable response. LOD was 
calculated using the following formula and shown in Table 
no. 1. 
LOD = 3.3 (SD/ S) 
Where, 
S = Slope of calibration curve 
SD = standard deviation of the response. 
The Limit of Quantification (LOQ) is the smallest 
concentration of the analyte, which gives a response that can 
be accurately quantified. LOQ was calculated using the 
following formula and shown in Table no…. 
LOQ = 10 (SD/ S) 
Where, 
S = slope of calibration curve 
SD = standard deviation of the response.16 
RESULT AND DISCUSSION 
The absorption spectrum of Product was measured in the 
range 200–400 nm against the blank solution Methanol 
similarly prepared. The standard solution show maximum 
absorbance at λ max for each three systems as recorded in 
Table 1. And the method was validated by studying the 
following parameters. The optimum conditions for UV 
spectroscopy method has been established by varying the 
parameters one at a time and keeping the other parameters 
fixed and observing the effects of products on the 
absorbance of the sample and colour species. Beer’s law 
limits, molar absorptivity and % relative standard deviation 
are summarized in Table 1. The regression analysis using the 
method of least squares was made for the slope (b), 
intercept(a) and correlation coefficient (r2)obtained from 
different concentrations are given in Table 1. The results 
showed that the method have reasonable precision. To 
evaluate the validity and reproducibility of the methods, 
known amounts of pure drug were added to the previously 
analyzed pharmaceutical powder forms analyzed by the 




Table No. 1: Optimum conditions, Optical characteristics and Statistical data of the regression equation in UV method 
with product 
Sr. No. Parameter Proposed method 
1. Regression equation Y=0.0762x – 0.0077 
2. Slope 0.0762 
3. Correlation coefficietion 0.9985 
4. Linear range(ppm) 1-10μg/ml 
5. Molar absorptivity (L.mol-1 .cm-1) 0.765 
6. Limit of detection (LOD) 0.2367 
7. Limit of quantification (LOQ) 0.7178 
8. Recovery 93.3% 
9. Lambda max (nm) 226nm 
10. Intercept (a) 0.0077 
 
 
Compare peaks of Amlodipine Besylate with synthesised product 
 
Figure no. 1: Peak of Amlodipine Besylate 
 
Figure no. 2: Peak of synthesised product
The above peaks of Amlodipine Besylate and synthesised product denoted that is the synthesised product peak is higher than 
the Amlodipine Besylate peak. 
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Calibration curve of Amlodipine Besylate and Product 
A calibration curve constructed with our method at the 
absorbance at 237nm, showed linearity in the range 1 - 10 
μg/mL for Amlodipine Besylate and at 226nm 1 – 10 μg/mL 
for Product, with r2 of 0.998 and 0.9985 respectively. The 
wavelength of 237 nm was selected for Amlodipine Besylate 
because the two absorption maxima in the UV region (359.6 
nm and 285 nm) were not suitable. The wavelength of 
226nm was selected for product because the two absorption 
maxima in the UV region (271.4 nm and 260.8 nm) were not 
suitable.
  
Table No. 3: Calibration curve of Amlodipine Besylate and Product 
Sr. No. Concentration Amlodipine Besylate Product 
1. 1 μg/ml 0.016 0.077 
2. 2 μg/ml 0.050 0.151 
3. 3 μg/ml 0.092 0.216 
4. 4 μg/ml 0.115 0.297 
5. 5 μg/ml 0.146 0.368 
6. 6 μg/ml 0.178 0.450 
7. 7 μg/ml 0.216 0.530 
8. 8 μg/ml 0.249 0.606 
9. 9 μg/ml 0.273 0.676 
10. 10 μg/ml 0.303 0.765 
 
 
Graph no. 1: Calibration curve of Amlodipine Besylate 
 
 
Graph no. 2: Calibration curve of Product 
 
CONCLUSION  
The proposed method is found to be simple, rapid, selective 
and highly sensitive than most of the spectrophotometric 
methods available in literature. The statistical parameters 
and the recovery study data clearly indicate the 
reproducibility and accuracy of the method. Thus the 
method can be adopted as an excellent spectrophotometric 
method. It is therefore recommended as an alternative 
method for routine quality control of Amlodipine Besylate.
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